Health professionals have a new website in the areas of neuroscience and rare diseases

Health professionals have a new website where they can find scientific information in the fields of neuroscience, rare diseases and biosimilar medicines. The myBiogen platform was launched by the neuroscience biotechnology company Biogen and aims to facilitate data collection and make it faster.

With exclusive access to health professionals, the platform provides a set of content and news related to neuroscience about new clinical and scientific developments. Registrants also find information to support clinical practice in multiple sclerosis and spinal muscular atrophy or on biosimilar medicines. Consult articles written by experts another possibility.


Health professionals can also have access to an updated calendar of congresses and other scientific events. The platform also allows requests for scientific documentation, which can be useful for clarifying doubts about the biotechnology company's medicines or therapeutic areas.

In a statement, the director general of Biogen Portugal makes clear the mission of the platform. "We want this website to be, above all, a space for sharing knowledge and experiences, he says. By the end of the year, the company expects to have around 500 health professionals registered on the platform.